:

Patrick E Duffy1, J Patrick Gorres2, Sara A Healy2

  • 1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. patrick.duffy@nih.gov.

PubMed
概括

疟疾疫苗RTS,S和R21提供了对抗药物耐药性和高死亡率的希望. 新的疫苗研究旨在提高疗效,并打击各种疟疾威胁,包括Plasmodium vivax.